Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Med Sci (Paris) ; 31(11): 979-88, 2015 Nov.
Article in French | MEDLINE | ID: mdl-26576605

ABSTRACT

Sheltered in a bony cage, populated by cells with little regenerative potential, the central nervous system (CNS) could likely not withstand classic inflammation without risking major sequelae. As a consequence, it had to develop an original way to provide surveillance, defence and reparation, which relies on both the complex architecture of the periphery-nervous parenchyma exchange zones, and the tightly regulated collaboration between all the cell populations that reside in or pass through the CNS. Despite its tight regulation, neuroinflammation is sometimes the cause of irreversible loss but it is also where the solution stands. The specific immune crosstalk that takes place in the CNS needs to be decoded in order to identify the best therapeutic strategies aimed at helping the CNS to restore homeostasis in problematic situations, such as in the case of neurodegenerative disorders. This review deals with this double-edged sword nature of neuroinflammation.


Subject(s)
Central Nervous System/immunology , Central Nervous System/pathology , Inflammation/etiology , Neurodegenerative Diseases/etiology , Astrocytes/physiology , Blood-Brain Barrier/physiology , Central Nervous System/cytology , Humans , Immunologic Surveillance/physiology , Microglia/physiology , Neurodegenerative Diseases/immunology , Neurons/physiology , Oligodendroglia/physiology
2.
Oxid Med Cell Longev ; 2012: 921941, 2012.
Article in English | MEDLINE | ID: mdl-22919443

ABSTRACT

A growing body of evidence indicates that the majority of Parkinson's disease (PD) cases are associated with microglia activation with resultant elevation of various inflammatory mediators and neuroinflammation. In this study, we investigated the effects of 2 natural molecules, quercetin and sesamin, on neuroinflammation induced by the Parkinsonian toxin 1-methyl-4-phenylpyridinium (MPP(+)) in a glial-neuronal system. We first established that quercetin and sesamin defend microglial cells against MPP(+)-induced increases in the mRNA or protein levels of 3 pro-inflammatory cytokines (interleukin-6, IL-1ß and tumor necrosis factor-alpha), as revealed by real time-quantitative polymerase chain reaction and enzyme-linked immunoabsorbent assay, respectively. Quercetin and sesamin also decrease MPP(+)-induced oxidative stress in microglial cells by reducing inducible nitric oxide synthase protein expression as well as mitochondrial superoxide radicals. We then measured neuronal cell death and apoptosis after MPP(+) activation of microglia, in a microglial (N9)-neuronal (PC12) coculture system. Our results revealed that quercetin and sesamin rescued neuronal PC12 cells from apoptotic death induced by MPP(+) activation of microglial cells. Altogether, our data demonstrate that the phytoestrogen quercetin and the lignan sesamin diminish MPP(+)-evoked microglial activation and suggest that both these molecules may be regarded as potent, natural, anti-inflammatory compounds.


Subject(s)
Cytoprotection/drug effects , Dioxoles/pharmacology , Dopaminergic Neurons/pathology , Inflammation/pathology , Lignans/pharmacology , Microglia/pathology , Neurons/pathology , Quercetin/pharmacology , 1-Methyl-4-phenylpyridinium/toxicity , Animals , Apoptosis/drug effects , Coculture Techniques , Cytokines/genetics , Cytokines/metabolism , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Gene Expression Regulation/drug effects , Kinetics , Mice , Microglia/drug effects , Microglia/enzymology , Mitochondria/drug effects , Mitochondria/metabolism , Neurons/drug effects , Neurons/enzymology , Neuroprotective Agents/pharmacology , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , PC12 Cells , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Superoxides/metabolism
3.
Oxid Med Cell Longev ; 1(1): 54-62, 2008.
Article in English | MEDLINE | ID: mdl-19794909

ABSTRACT

Oxidative stress is regarded as a mediator of nerve cell death in several neurodegenerative disorders, such as Parkinson's disease. Sesamin, a lignan mainly found in sesame oil, is currently under study for its anti-oxidative and possible neuroprotective properties. We used 1-methyl-4-phenyl-pyridine (MPP(+)) ion, the active metabolite of the potent parkinsonism-causing toxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, to produce oxidative stress and neurodegeneration in neuronal PC12 cells, which express dopamine, as well as neurofilaments. Our results show that picomolar doses of sesamin protected neuronal PC12 cells from MPP(+)-induced cellular death, as revealed by colorimetric measurements and production of reactive oxygen species. We also demonstrated that sesamin acted by rescuing tyrosine hydroxylase levels from MPP(+)-induced depletion. Sesamin, however, did not modulate dopamine transporter levels, and estrogen receptor-alpha and -beta protein expression. By examining several parameters of cell distress, we found that sesamin also elicited a strong increase in superoxide dismutase activity as well as protein expression and decreased catalase activity and the MPP(+) stimulated inducible nitric oxide synthase protein expression, in neuronal PC12 cells. Finally, sesamin possessed significant anti-inflammatory properties, as disclosed by its potential to reduce MPP(+)-induced interleukin-6 mRNA levels in microglia. From these studies, we determined the importance of the lignan sesamin as a neuroprotective molecule and its possible role in complementary and/or preventive therapies of neurodegenerative diseases.


Subject(s)
Catalase/biosynthesis , Dioxoles/pharmacology , Interleukin-6/biosynthesis , Lignans/pharmacology , Nitric Oxide Synthase Type II/biosynthesis , Oxidative Stress/physiology , Superoxide Dismutase/biosynthesis , Tyrosine 3-Monooxygenase/biosynthesis , 1-Methyl-4-phenylpyridinium/pharmacology , Animals , Antioxidants/pharmacology , Catalase/metabolism , Dopamine/metabolism , Dopamine Plasma Membrane Transport Proteins/metabolism , Interleukin-6/metabolism , Neurons/drug effects , Neurons/enzymology , Neurons/metabolism , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , PC12 Cells , Rats , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...